Increased Doses Lead to Higher Drug Exposures of Levofloxacin for the Treatment of Tuberculosis.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00770-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacokinetics of Levofloxacin in Multidrug- And Extensively Drug-Resistant Tuberculosis Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin

Organic Letters
BiochemistryOrganic ChemistryTheoretical ChemistryPhysical
2014English

Pulmonary Drug Delivery Systems for the Treatment of Tuberculosis

Drug Delivery System
Pharmaceutical Science
2008English

Computer Code for Calculating Personnel Doses Due to Tritium Exposures

1977English

Higher Dosage of HIFU Treatment May Lead to Higher and Longer Efficacy for Moderate to Severe Perennial Allergic Rhinitis

International Journal of Medical Sciences
Medicine
2013English

Determination of MICs of Levofloxacin for Mycobacterium Tuberculosis With gyrA Mutations

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2015English

Drug Treatment of Tuberculosis: I. Standard Chemotherapy

BMJ
1960English

Modern Drug Treatment in Tuberculosis

British Journal of Diseases of the Chest
1984English

An Optimized Background Regimen Design to Evaluate the Contribution of Levofloxacin to Multidrug-Resistant Tuberculosis Treatment Regimens: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy